J, H., W, X., M, W., Y, W., M, S., Y, Z., . . . S, L. (2021). MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis. Dove Medical Press.
Chicago Style (17th ed.) CitationJ, Huang, Xue W, Wang M, Wu Y, Singh M, Zhu Y, Kumar R, and Lin S. MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis. Dove Medical Press, 2021.
MLA (8th ed.) CitationJ, Huang, et al. MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis. Dove Medical Press, 2021.
Warning: These citations may not always be 100% accurate.